Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs
Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”
Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.
| City | Minimum Cost (USD) | Minimum Cost (TRY) | Maximum Cost (USD) | Maximum Cost (TRY) |
|---|---|---|---|---|
| Ankara | USD 25000 | 976500 | USD 55000 | 2148300 |
| Istanbul | USD 25000 | 976500 | USD 55000 | 2148300 |
| Izmir | USD 25000 | 976500 | USD 55000 | 2148300 |
| Samsun | USD 25000 | 976500 | USD 55000 | 2148300 |
| Tokat | USD 22500 | 878850 | USD 49500 | 1933470 |
| City | Cost (USD) | |
|---|---|---|
| Ankara | $120,000 – $175,000 | Explore More |
| Istanbul | $120,000 – $175,000 | Explore More |
| Izmir | $120,000 – $175,000 | Explore More |
| Kocaeli | $120,000 – $175,000 | Explore More |
| Samsun | $120,000 – $175,000 | Explore More |
| Tokat | $108,000 – $157,500 | Explore More |
Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.
With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.
Readers can explore her published research and articles here:
Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.
CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.
This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.
CAR T cell therapy is classified as follows:
Antigen-based classification: It includes
CAR T-cell therapy is primarily used to treat blood cancers, such as multiple myeloma, large B-cell lymphoma, and B-cell acute lymphoblastic leukaemia. The patient's own T cells are reprogrammed to identify and destroy cancer cells, cause remission, enhance survival, and have a plan B in case other treatments fail.
Patients with blood cancers who relapsed or are refractory must consult an oncologist to determine candidacy for CAR T therapy, especially if they have failed to respond to traditional treatments (i.e., chemotherapy, radiation, or stem cell transplant). Evaluation is warranted for symptoms such as loss of weight, swelling of lymph nodes, recurrent infection, chronic fatigue, or spontaneous bruising.
Screening tests consist of imaging, bone marrow biopsy, and blood work.
Leukapheresis is utilised to harvest T cells from the patient's blood for T-cell collection.
Bridging therapy: Certain patients receive chemotherapy while waiting for CAR T cells to be produced.
Lymphodepleting chemotherapy is administered before the injection to make room for CAR T cells. The patients should plan for potential hospitalisation, designate caretakers, and discuss long-term follow-up and expected adverse effects with the medical team.
The whole process, from cell harvesting to infusion, can take three to six weeks. The infusion itself takes a few hours to a few minutes, but for at least one week following the infusion, close monitoring is required, and there will be frequent follow-ups for several months.
One of the newer treatment options for some blood cancers is CAR T-cell therapy. It is utilised when other treatments are not working or the cancer recurs. CAR T-cell therapy has the potential to cure many blood cancers and extend life in most cases.
Recovery involves managing side effects like CRS and neurotoxicity, monitoring blood levels, and avoiding infections. Laboratory testing, imaging, and monitoring for late issues like hypogammaglobulinemia or relapse are all included in long-term follow-up.
The nature of the cancer, the burden of the disease, and an individual's response all impact success. For example, in pediatric acute lymphoblastic leukaemia, complete remission rates are more than 80%. However, relapse is always a risk, and long-term success is variable.
80%
Complete remission (pediatric ALL)2 days
in hospital post-infusion3 Months
to typical return to workOur experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.
✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours
Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Hendrik decided to come to India for his treatment after a thorough discussion with MediGence. India is known for its…
The cost of CAR-T in Tokat may differ from one medical facility to the other. Some of the best hospitals for CAR-T offer a comprehensive package that covers the end-to-end expenses related to investigations and treatment of the patient. The CAR-T package in Tokat includes the fees of the surgeon, hospitalization and anesthesia as well. Post-surgical complications, new findings and delayed recovery may have an impact on the total CAR-T cost in Tokat.
Many hospitals in Tokat perform CAR-T. For quick reference, the following are some of the leading hospitals for CAR-T in Tokat:
The recovery of the patient many vary, depending on several factors. However, on an average, patient is supposed to stay for about 28 days in the country after discharge. This period is important to conduct all the follow-up tests to ensure that the surgery was successful and the patient can go back to the home country.
There are certain additional cost that the patient has to pay apart from the CAR-T cost. These include the cost of accommodation and meals outside hospital. The per day cost in this case may range from 40 USD.
After the CAR-T surgery takes place, the average duration of stay at the hospital is about 2 Days. The patient is subjected to several biochemistry and radiological scans to see that everything is okay and the recovery is on track. After making sure that patient is clinically stable, discharge is planned.
There are around 1 Hospitals hospitals in Tokat that offer CAR-T to international patients. These hospitals have the required infrastructure and a decided CAR-T unit where renal failure patients can be treated. Additionally, these hospitals are known to comply with the international standards as well as local legal requirements for the treatment of patients.
Some of the most sought after doctors for CAR-T in Tokat are:
Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.
Upload Your Reports
